Marina Biotech Report issue

For profit Phase 2
Founded: City of Industry CA United States (2010)
Status: Acquired by Adhera (2018)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (5)

Key: Marina Biotech (0) Acquired (5)

insulin human (humulin) (1 trial)

insulin lispro (humalog) (1 trial)

pyy 3-36 (1 trial)

sibutramine (meridia) (1 trial)

teriparatide (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 3
  • # of Trial APIs: 5